Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Studies show BPC-157 accelerates healing through multiple mechanisms: increased angiogenesis (new blood vessel formation) by 129-152%, enhanced collagen synthesis, reduced inflammation, and faster re-epithelialization
Anticipated Costs Post-Approval While neither compound has reached market, pricing for similar medications provides context: Semaglutide (Wegovy) Approximately $1,300-$1,500 monthly without insurance Tirzepatide (Zepbound) Approximately $1,000-$1,200 monthly without insurance Cagrilintide and retatrutide would likely fall in similar price ranges, with combination therapy potentially costing $2,000-$3,000 monthly without insurance coverage
This selective removal reduces inflammation and allows for the restoration of healthy tissue (5)
Other reported effects Beyond GI symptoms, clinical trials noted several other effects worth monitoring: Increased heart rate: A small, dose-dependent increase in resting heart rate was observed, consistent with what occurs with other GLP-1 agonists
Over-dilution problems Adding too much water creates a solution so dilute that practical dosing becomes difficult or impossible
Usually no - GHK-Cu protocols use fixed doses rather than mg/kg calculations
